Optimal duration of antiplatelet therapy after implantation of a small-diameter polytetrafluoroethylene arterial prosthesis.
A G
AG
Nordestgaard
L P
LP
Moller
C S
CS
Marcus
S E
SE
Wilson
D000818:Animals; D001241:Aspirin / Q000627:therapeutic use*; D001807:Blood Vessel Prosthesis; D004176:Dipyridamole / Q000627:therapeutic use*; D006083:Graft Occlusion, Vascular / Q000517:prevention & control*; D008297:Male; D011138:Polytetrafluoroethylene; D011817:Rabbits; D013997:Time Factors
D004176:Dipyridamole; D011138:Polytetrafluoroethylene; D001241:Aspirin